Biogen bolsters ischaemic stroke pipeline with thrombolytic ...
Biogen has licensed a new drug from Japanese biotech TMS that it hopes could provide a big advance on an old treatment approach – using clot-busting thrombolytic drugs to treat ischaemic st
